SCHEMBL4032580

SCHEMBL4032580

Cn1nccc1-c1cc(NC(=O)COc2ccc(OC(F)(F)F)cc2)ccc1OCCN1CCCC1

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 20/20 0.67
HTR2C P28335 18/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3954305 0.94 HTR2A (0.68) HTR2AHTR2C
SCHEMBL3949362 0.92 HTR2A (0.65) HTR2AHTR2C
SCHEMBL14385338 0.92 HTR2A (0.79) HTR2AHTR2C
SCHEMBL14384635 0.91 HTR2A (0.79) HTR2AHTR2C
SCHEMBL4035855 0.90 HTR2A (0.80) HTR2AHTR2C
SCHEMBL14384627 0.90 HTR2A (0.78) HTR2AHTR2C
SCHEMBL14385011 0.90 HTR2A (0.81) HTR2AHTR2C
SCHEMBL1165639 0.89 HTR2A (0.83) HTR2AHTR2C
SCHEMBL4041361 0.89 HTR2A (0.79) HTR2AHTR2C
SCHEMBL14384630 0.89 HTR2A (0.79) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051978-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-04-29 EP claimed
WO-2007136875-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO claimed